Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- Horizon Discovery
- 8100 Cambridge Research Park
- Cambridge , CB25 9TL
- UNITED KINGDOM
Horizon Discovery is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them to advance human health. Horizon’s catalogue of over 23,000 models supports the understanding of the genetic drivers of disease, and underpins a broad range of services and Horizon’s own R&D pipeline.